Ta strona została przetłumaczona automatycznie i dokładność tłumaczenia nie jest gwarantowana. Proszę odnieść się do angielska wersja za tekst źródłowy.

Dose Response of Leucine on Muscle Maintenance During Weight Loss

17 sierpnia 2026 zaktualizowane przez: Nanyang Technological University

The objective of this research is to determine if there is dose response of leucine on muscle maintenance during 4-week of alternate-day fasting (ADF) on blood parameters, body composition, mood and parameters related to appetite in young men with a body mass index of 23kg/m2 and above, whose body mass falls outside of the healthy range for their height (Asian reference point for increased risk of cardiovascular diseases). Participants have no diagnoses of, and are not prescribed medications for, cardiovascular, metabolic, diabetic, lung (except controlled asthma), kidney, or joint health conditions.

To achieve this objective, 100 hundred young men, aged between 21 and 35 years old will be recruited to complete a 4-week ADF programme. The fasting programme starts at 12 midnight and alternates between fasting and feeding days. Each fasting or feeding day is 24 hours in duration. During fasting days, participants abstain from all food and beverages except for ad libitum plain water and other zero-calorie beverages, and a small meal amounting to 25% of daily caloric need. This small meal must be consumed between 12 pm and 2 pm in this study, for standardization to ensure consistency in the total duration of fasting and feeding. During feeding days, participants eat up to approximately 125% of daily caloric need (calculated weekly), with no restriction on meal timing as long as meals are consumed within the 24-hour period. The programme ends after 4 weeks (28 days) of continuous ADF

All food for the 4-week ADF will be provided. Participants will be randomly assigned (double blind) to the amount of leucine in their diet: 0.02, 0.04, 0.06 or 0.08 g/kg body mass per meal for 1 meal/day on fasting days and 3 meals/day on feeding days.

Blood parameters, body mass, height, waist-to-hip ratio, body composition, mood, stress level, and parameters related to eating and appetite will be measured before and after 4-week of ADF.

The investigators hypothesised a dose response in leucine to maintain muscle mass during weight loss.

Przegląd badań

Status

Zakończony

Warunki

Interwencja / Leczenie

Szczegółowy opis

Participation in this study requires a total of 4 weeks of ADF and 6 laboratory visits (sessions) spread over 5-6 weeks.

To participate in this study, participants will have to:

  • complete the questionnaires regarding their health and diet and physical activity level (Global Physical Activity Questionnaire) on session 1,
  • complete 5 weekly measurements of resting blood pressure and heart rate, fasting blood glucose (via finger prick blood sample), body mass, height, waist and hip circumferences, and body composition using bioelectrical impedance analysis (BIA) on sessions 1 and 3-6,
  • complete the questionnaires regarding their mood [Brunel Mood Scale (BRUMS)], stress [Perceived Stress Scale (PSS)], food craving for general and specific foods [Food Craving Questionnaire-Trait Reduced (FCQ-T-r), and Food Craving Inventory (FCI)], eating behaviour [Three-Factor Eating Questionnaire-R18 - cognitive restraint component (TFEQ-r18)], and appetite, hunger, satiety and diet satisfaction (visual analogue scales, questionnaire and computerised test) twice on sessions 1 and 6,
  • provide blood samples twice on sessions 1 and 6 for various biomarkers,
  • complete 2 occasions of body composition measurement using dual-energy X-ray absorptiometry (DXA) on sessions 1 and 6,
  • complete 4 weeks of ADF as instructed (details given below),
  • consume only the food provided (high protein diet with leucine supplement) except for ad libitum intake of plain water and zero caloric beverages during the 4 weeks of ADF,
  • complete daily log of food intake (including leftover/unconsumed food), physical activity and sleep during the entire 4 weeks of ADF,
  • maintain a consistent diet between session 1 and the start of ADF,
  • maintain a consistent physical activity level throughout the entire study. Do not start a new exercise programme during the entire duration of the study, and
  • abstain from high level of physical activity throughout the entire study.

Prior to each session except session 2, participants are also required to:

  • Abstain from any physical activity except activities of daily living for at least 48 hours.
  • Abstain from alcohol and caffeine for at least 24 hours.
  • Fast (i.e. do not eat or drink except plain water) overnight for 10 hours. In consideration of the fasting, these sessions will take place in the morning. To control for diurnal variation, the sessions will be timed such that the same measurements will be taken at approximately the same time of the day (+/- 1 hour difference).
  • Obtain a full night of sleep the night before.

The above dietary and physical activity restriction is to minimise the confounding effects of diet and physical activities external to those conducted in this study.

Participants will also be instructed to:

  • Inform the investigators immediately if they fall ill during the study or discover a health condition that requires them to consume any medication, steroids or hormones, and
  • NOT to take calcium supplements or antacids (e.g. TUMS®) at least 24 hours prior to session 1, and NOT to schedule any scan that involves a contrast agent or ingestion of barium at least 14 days prior to sessions 1 and 6 to ensure accuracy of the DXA scans for body composition.

All sessions will be done in a fasted and rested state except session 2.

Session 1:

• Read and sign consent form

  • Pre-screening:

    o Complete questionnaire on health and diet

    • Resting blood pressure and heart rate
    • Fasting blood glucose (via finger prick)
    • Body mass
    • Height
  • Complete questionnaires on physical activity level, mood, stress, food craving, eating behaviour, appetite, hunger, satiety and diet satisfaction
  • Antecubital blood sample
  • Waist and hip circumference measurements
  • Body composition using dual-energy X-ray absorptiometry and bioelectrical impedance analysis

Session 2: collection of 1 week of food. ADF will start within 10 days from session 1. Body mass and height

Session 3: 7 days (1 week) after the start of ADF

  • Health measurements as in session 1:

    • Resting blood pressure and heart rate
    • Fasting blood glucose (via finger prick)
    • Body mass and height
    • Waist and hip circumferences
    • Body composition using bioelectrical impedance analysis
  • Collection of 1 week of food

Session 4: 14 days (2 weeks) after start of fasting programme

• Same as session 3

Session 5: 21 days (3 weeks) after start of fasting programme

• Same as session 3

Session 6: 28 days (4 weeks) after start of fasting programme

• Same as session 1 except consent and pre-screening questionnaires on health and diet, and physical activity level are not applicable

Typ studiów

Interwencyjne

Zapisy (Rzeczywisty)

92

Faza

  • Nie dotyczy

Kontakty i lokalizacje

Ta sekcja zawiera dane kontaktowe osób prowadzących badanie oraz informacje o tym, gdzie badanie jest przeprowadzane.

Lokalizacje studiów

  • Singapur
      • Singapore, Singapur, 637616
        • Nanyang Technological University

Kryteria uczestnictwa

Badacze szukają osób, które pasują do określonego opisu, zwanego kryteriami kwalifikacyjnymi. Niektóre przykłady tych kryteriów to ogólny stan zdrowia danej osoby lub wcześniejsze leczenie.

Kryteria kwalifikacji

Wiek uprawniający do nauki

  • Dorosły

Akceptuje zdrowych ochotników

Nie

Opis

Inclusion Criteria:

  • Male
  • 21 to 35 years old
  • Do not smoke or use tobacco products (including shisha)
  • Have a body mass index (BMI = body mass in kilograms divided by the square of height in metres) of 23 or greater

Exclusion Criteria:

  • Unable to adhere to the requirements regarding physical activity and diet as stated in the research methodologies.
  • Allergic or intolerant to milk and soy.
  • Any other food allergies or dietary restrictions/preferences that the research team is unable to cater to due to constraints in food preparation and choices in order to control for composition of macronutrients, leucine content and calories in the food provided.
  • Failed an exercise stress test.
  • Have any health condition(s) that would be made worse by fasting.
  • Taking long-term prescribed medication(s) for heart, blood (including blood sugar and blood pressure), lung (except controlled asthma), liver, kidney or joint condition(s).
  • Taking other prescribed medication (including traditional Chinese medicine and other alternative medicine), drugs, steroids, or hormones that can affect any of the measurements in this study.
  • Have electrical implant (such as pacemaker, implantable cardioverter defibrillator or neurostimulator), metal or plastic implant/rod/plate, or joint replacement in the body as these objects can affect the accuracy of the body composition measurement.

Plan studiów

Ta sekcja zawiera szczegółowe informacje na temat planu badania, w tym sposób zaprojektowania badania i jego pomiary.

Jak projektuje się badanie?

Szczegóły projektu

  • Główny cel: Leczenie
  • Przydział: Randomizowane
  • Model interwencyjny: Przydział równoległy
  • Maskowanie: Potroić

Broń i interwencje

Grupa uczestników / Arm
Interwencja / Leczenie
Eksperymentalny: 0.02g/kg body mass per meal
In this study, participants would be randomly (by chance) assigned to the amount of leucine in their diet: 0.02, 0.04, 0.06 or 0.08 g/kg body mass per meal for 1 meal/day on fasting days and 3 meals/day on feeding days.
Suplement diety: leucine
0.02g/kg body mass/meal
Suplement diety: leucine
0.04g/kg body mass/meal
Suplement diety: leucine
0.06g/kg body mass/meal
Suplement diety: leucine
0.08g/kg body mass/meal
Eksperymentalny: 0.04g/kg body mass per meal
In this study, participants would be randomly (by chance) assigned to the amount of leucine in their diet: 0.02, 0.04, 0.06 or 0.08 g/kg body mass per meal for 1 meal/day on fasting days and 3 meals/day on feeding days.
Suplement diety: leucine
0.02g/kg body mass/meal
Suplement diety: leucine
0.04g/kg body mass/meal
Suplement diety: leucine
0.06g/kg body mass/meal
Suplement diety: leucine
0.08g/kg body mass/meal
Eksperymentalny: 0.06g/kg body mass per meal
In this study, participants would be randomly (by chance) assigned to the amount of leucine in their diet: 0.02, 0.04, 0.06 or 0.08 g/kg body mass per meal for 1 meal/day on fasting days and 3 meals/day on feeding days.
Suplement diety: leucine
0.02g/kg body mass/meal
Suplement diety: leucine
0.04g/kg body mass/meal
Suplement diety: leucine
0.06g/kg body mass/meal
Suplement diety: leucine
0.08g/kg body mass/meal
Eksperymentalny: 0.08g/kg body mass per meal
In this study, participants would be randomly (by chance) assigned to the amount of leucine in their diet: 0.02, 0.04, 0.06 or 0.08 g/kg body mass per meal for 1 meal/day on fasting days and 3 meals/day on feeding days.
Suplement diety: leucine
0.02g/kg body mass/meal
Suplement diety: leucine
0.04g/kg body mass/meal
Suplement diety: leucine
0.06g/kg body mass/meal
Suplement diety: leucine
0.08g/kg body mass/meal

Co mierzy badanie?

Podstawowe miary wyniku

Miara wyniku
Opis środka
Ramy czasowe
Lean mass
Ramy czasowe: Start and end of 4-week intervention
Lean mass measured using DXA
Start and end of 4-week intervention
Appendicular Lean Mass
Ramy czasowe: Start and end of 4-week intervention
Sum of lean mass in upper and lower limbs measured using DXA
Start and end of 4-week intervention
Body mass index
Ramy czasowe: Start and end of 4-week intervention and weekly during intervention
body mass in kilograms divided by sqaure of height in metres
Start and end of 4-week intervention and weekly during intervention
Lean mass index
Ramy czasowe: Start and end of 4-week intervention
lean mass in kilograms divided by square of height in metres
Start and end of 4-week intervention
Appendicular lean mass index
Ramy czasowe: Start and end of 4-week intervention
Appendicular lean mass in kilograms divided by square of height in metres
Start and end of 4-week intervention
Fat mass
Ramy czasowe: Start and end of 4-week intervention and weekly during intervention
Fat mass
Start and end of 4-week intervention and weekly during intervention
Percentage body fat
Ramy czasowe: Start and end of 4-week intervention and weekly during intervention
Percentage body fat
Start and end of 4-week intervention and weekly during intervention
Fat mass index
Ramy czasowe: Start and end of 4-week intervention and weekly during intervention
Fat mass in kilograms divided by square of height in metres
Start and end of 4-week intervention and weekly during intervention
Trunk fat
Ramy czasowe: Start and end of 4-week intervention
Fat mass around the trunk
Start and end of 4-week intervention
Appendicular fat mass
Ramy czasowe: Start and end of 4-week intervention
Sum of fat mass in the upper and lower limbs
Start and end of 4-week intervention
Resting systolic blood pressure
Ramy czasowe: Start and end of 4-week intervention and weekly during intervention
Start and end of 4-week intervention and weekly during intervention
Resting diastolic blood pressure
Ramy czasowe: Start and end of 4-week intervention and weekly during intervention
Start and end of 4-week intervention and weekly during intervention
Fasting blood glucose
Ramy czasowe: Start and end of 4-week intervention and weekly during intervention
Start and end of 4-week intervention and weekly during intervention
HbA1c
Ramy czasowe: Start and end of 4-week intervention
Start and end of 4-week intervention
Insulin
Ramy czasowe: Start and end of 4-week intervention
Start and end of 4-week intervention
The HOMA-IR index
Ramy czasowe: Start and end of 4-week intervention
Homeostatic Model Assessment of Insulin Resistance index
Start and end of 4-week intervention
Total cholesterol
Ramy czasowe: Start and end of 4-week intervention
Start and end of 4-week intervention
HDL cholesterol
Ramy czasowe: Start and end of 4-week intervention
Start and end of 4-week intervention
LDL cholesterol
Ramy czasowe: Start and end of 4-week intervention
Start and end of 4-week intervention
Total cholesterol to HDL cholesterol ratio
Ramy czasowe: Start and end of 4-week intervention
Start and end of 4-week intervention
Triglycerides
Ramy czasowe: Start and end of 4-week intervention
Start and end of 4-week intervention
Body mass
Ramy czasowe: Start and end of 4-week intervention and weekly during intervention
Body mass
Start and end of 4-week intervention and weekly during intervention
Appendicular fat mass index
Ramy czasowe: Start and end of 4-week intervention
Appendicular fat mass in kilograms divided by square of height in metres
Start and end of 4-week intervention

Miary wyników drugorzędnych

Miara wyniku
Opis środka
Ramy czasowe
Appendicular fat-free mass index
Ramy czasowe: Start and end of 4-week intervention and weekly during intervention
Appendicular fat-free mass in kilograms divided by square of height in metres
Start and end of 4-week intervention and weekly during intervention
Android fat mass
Ramy czasowe: Start and end of 4-week intervention
Start and end of 4-week intervention
Gynoid fat mass
Ramy czasowe: Start and end of 4-week intervention
Start and end of 4-week intervention
Bone mineral content
Ramy czasowe: Start and end of 4-week intervention
Bone mass
Start and end of 4-week intervention
Bone mineral density
Ramy czasowe: Start and end of 4-week intervention
Bone mineral density
Start and end of 4-week intervention
Waist Circumference
Ramy czasowe: Start and end of 4-week intervention and weekly during intervention
Waist Circumference
Start and end of 4-week intervention and weekly during intervention
Hip circumference
Ramy czasowe: Start and end of 4-week intervention and weekly during intervention
Start and end of 4-week intervention and weekly during intervention
Waist-to-hip ratio
Ramy czasowe: Start and end of 4-week intervention and weekly during intervention
Waist circumference to hip circumference ratio
Start and end of 4-week intervention and weekly during intervention
Fat free mass
Ramy czasowe: Start and end of 4-week intervention and weekly during intervention
Fat free mass measured using BIA
Start and end of 4-week intervention and weekly during intervention
Skeletal muscle mass
Ramy czasowe: Start and end of 4-week intervention and weekly during intervention
Skeletal muscle mass measured using BIA
Start and end of 4-week intervention and weekly during intervention
Appendicular fat-free mass
Ramy czasowe: Start and end of 4-week intervention and weekly during intervention
Sum of fat free mass in upper and lower limbs measured using BIA
Start and end of 4-week intervention and weekly during intervention
Visceral fat area
Ramy czasowe: Start and end of 4-week intervention and weekly during intervention
Visceral fat area measured using BIA
Start and end of 4-week intervention and weekly during intervention
Fat-free mass index
Ramy czasowe: Start and end of 4-week intervention and weekly during intervention
Fat-free mass in kilograms divided by square of height in metres
Start and end of 4-week intervention and weekly during intervention
Skeletal muscle mass index
Ramy czasowe: Start and end of 4-week intervention and weekly during intervention
Skeletal muscle mass in kilograms divided by square of height in metres
Start and end of 4-week intervention and weekly during intervention
Mood
Ramy czasowe: Start and end of 4-week intervention
Brunel Mood Scale (BRUMS). BRUMS is the modified and shorter version of the Profile of Mood Stats (POMS). The 24-item BRUMS was used to assess mood responses. It has six subscales (tension, depression, anger, vigour, fatigue, and confusion) of four mood descriptors each, with respondents rating how they feel "right now" on a 5-point Likert-type scale (0 = not at all, 1 = a little, 2 = moderately, 3 = quite a bit; 4 = extremely). During its development, the BRUMS showed robust psychometric properties across samples of adult students, adult athletes, young athletes, and schoolchildren, and has since demonstrated psychometric integrity for use with many other population groups (doi.org/10.3390/su13116116).For each subscale, the raw score are summed and converted to a T-score based on the norms published in the paper (doi.org/10.3390/su13116116). Higher T-score for each subscale reflects higher profile of that subscale (i.e. tension, depression, anger, vigour, fatigue, or confusion).
Start and end of 4-week intervention
Stress level
Ramy czasowe: Start and end of 4-week intervention
Perceived Stress Scale (PSS). The 10-item PSS asks participants about feelings and thoughts during the last month, with responses ranging from 0 (never) to 4 (very often). The final score obtained by reversing responses (e.g., 0 = 4, 1 = 3, 2 = 2, 3 = 1 & 4 = 0) to the four positively stated items (items 4, 5, 7, & 8) and then summing across all scale items. Higher scores indicating higher levels of perceived stress.
Start and end of 4-week intervention
Food craving - habitual
Ramy czasowe: Start and end of 4-week intervention
The Food Craving Questionnaire-Trait Reduced (FCQ-T-r) measures the habitual (unspecified time frame) trait craving for food in general. It predicts food cravings in daily life. It represents a stable trait but is also sensitive to changes in eating behaviour. The questionnaire consists of 15 questions, participants are required to rate the frequency of each statement with a 6-likert scale (never or not applicable = 1, to always = 6). By summing up the scores of the scales, higher scores represent higher level of food cravings.
Start and end of 4-week intervention
Food craving - specific foods
Ramy czasowe: Start and end of 4-week intervention
Food Craving Inventory (FCI) measures food craving for specific foods and the versions validated for use in United States and United Kingdom were used. Questionnaire items pertaining to specific local foods were also added for a combined total of 61 food items (i.e. questionnaire items). For each item, participants were asked how often they have experienced a craving for that particular food on a 5-point Likert scale (never = 1, to always/almost every day = 5). The higher the score, the higher the food craving.
Start and end of 4-week intervention
Eating Behaviour
Ramy czasowe: Start and end of 4-week intervention
Three-Factor Eating Questionnaire-R18 - cognitive restraint component (TFEQ-r18 Cog). It has 6 items and each scored 1 to 4 for a total of 24 points. The higher the total score, the more disordered the eating behaviour.
Start and end of 4-week intervention
Baseline appetite
Ramy czasowe: Start and end of 4-week intervention upon arrival in the laboratory
Baseline appetite using visual analogue scale 0 to 100. The higher the score, the higher the baseline appetite
Start and end of 4-week intervention upon arrival in the laboratory
Hunger over past 4 weeks
Ramy czasowe: Start (i.e. over the past 4 weeks before start of the intervention) and end of 4-week intervention (i.e. over the past 4 weeks during the intervention)
Hunger over past 4 weeks. Visual analogue scale 0 to 100. The higher the number the greater the amount of hunger.
Start (i.e. over the past 4 weeks before start of the intervention) and end of 4-week intervention (i.e. over the past 4 weeks during the intervention)
Satiety over past 4 weeks
Ramy czasowe: Start (i.e. over the past 4 weeks before start of the intervention) and end of 4-week intervention (i.e. over the past 4 weeks during the intervention)
Satiety over past 4 weeks. Visual analogue scale 0 to 100. The higher the number, the greater amount of satiety.
Start (i.e. over the past 4 weeks before start of the intervention) and end of 4-week intervention (i.e. over the past 4 weeks during the intervention)
Diet satisfaction over past 4 weeks
Ramy czasowe: Start (i.e. over the past 4 weeks before start of the intervention) and end of 4-week intervention (i.e. over the past 4 weeks during the intervention)
Diet satisfaction over past 4 weeks. Visual analogue scale 0 to 100. The higher the number the greater the satisfaction.
Start (i.e. over the past 4 weeks before start of the intervention) and end of 4-week intervention (i.e. over the past 4 weeks during the intervention)
Implicit satiety goal
Ramy czasowe: Start and end of 4-week intervention
Implicit satiety goal (unconscious, habitual, or subjective levels of fullness that individuals aim to achieve when eating) using visual analogue scale 0 to 100. The higher the number, the greater implicit satiety goal.
Start and end of 4-week intervention
Ideal portion size
Ramy czasowe: Start and end of 4-week intervention
Ideal portion size (IPS). Participants were presented with a diverse range of 25 foods typically consumed in Singapore. The computerised portion selection tasks presented a series of 50 images of each food that increased in portion size in 20 kcal increments (20-1000 kcal). Participants could increase or decrease the portion size by 20 kcal using the left and right arrow-keys on the keyboard and were encouraged to view the full range of portions before selecting their ideal portion. Foods were presented in a randomised order and an average portion size for each participant was calculated by averaging the selected portion sizes of all 25 foods (α = 0.95). This created an overall index of IPS.
Start and end of 4-week intervention
Expected satiety
Ramy czasowe: Start and end of 4-week intervention
Expected satiety (ES) measured using computerised task. The ES task followed the same format as the IPS task, in other words, 50 images were presented depicting 20 kcal increment changes in portion size. This task sought to measure participants' expectations about how satiating a diverse range of foods were. Larger portions selected indicated that participants require larger quantities of the food to delay the onset of hunger, in other words they have lower expected satiety. The same 25 foods presented in the IPS were also presented in the ES in a randomised order and were averaged to create an overall index of ES (α = 0.95).
Start and end of 4-week intervention
Food-related characteristics
Ramy czasowe: Start and end of 4-week intervention
A single image of each food item was presented to participants alongside questions of food-related characteristics. Participants were asked to rate how filling they expected each food to be (not filling at all (0) to very filling (100)), how much they like each food in general (not at all (0) to very much (100)) and how often they eat each food (never (0) to more than once a week (5)). Each food was presented in a randomised order and average scores across all 25 foods for participants perceptions of how filling, frequently consumed and preference for foods were calculated.
Start and end of 4-week intervention
Insulin growth factor-1
Ramy czasowe: Time Frame: Start and end of 4-week intervention
Time Frame: Start and end of 4-week intervention

Inne miary wyników

Miara wyniku
Opis środka
Ramy czasowe
Height
Ramy czasowe: Start and end of 4-week intervention and weekly
Height - used to calculate body mass index and other indices
Start and end of 4-week intervention and weekly
Hydration status
Ramy czasowe: Start and end of 4-week intervention and weekly during intervention
Intracellular water (litre)/extracellular water (litre). This ratio is a reflection of the hydration status in the body. Hydration status can affect the body composition measurements using BIA.
Start and end of 4-week intervention and weekly during intervention
SGP/ALT
Ramy czasowe: Start and end of 4-week intervention
blood biomarker of liver function
Start and end of 4-week intervention
SGOT/AST
Ramy czasowe: Start and end of 4-week intervention
blood biomarker of liver function
Start and end of 4-week intervention
Serum sodium
Ramy czasowe: Start and end of 4-week intervention
Start and end of 4-week intervention
Serum potassium
Ramy czasowe: Start and end of 4-week intervention
Start and end of 4-week intervention
Serum urea
Ramy czasowe: Start and end of 4-week intervention
Start and end of 4-week intervention
Serum creatinine
Ramy czasowe: Start and end of 4-week intervention
Start and end of 4-week intervention
Full blood count
Ramy czasowe: Start and end of 4-week intervention
Start and end of 4-week intervention
Weekly physical activity level
Ramy czasowe: 1-2 weeks before the start of the intervention and for each week of the 4-week intervention
Participants complete the type, intensity and duration of each physical activity during the week similar to Global Physical Activity Questionnaire (GPAQ) developed by the WHO. Each activity is calculated in Metabolic Equivalent (MET) value. Moderate MET value is 4.0 and vigorous MET value is 8.0 while for transport domains MET value is 4.0.
1-2 weeks before the start of the intervention and for each week of the 4-week intervention
Food diary
Ramy czasowe: Daily during the 4-week intervention
Participants have to record daily whether they finish the food provided, including the portion of leftovers if any. On fasting days, they also log the timing of their small meal
Daily during the 4-week intervention
Sleep diary
Ramy czasowe: Daily during the 4-week intervention
Participants have to log their sleep time, wake up time and subjective sleep quality daily
Daily during the 4-week intervention

Współpracownicy i badacze

Tutaj znajdziesz osoby i organizacje zaangażowane w to badanie.

Sponsor

Nanyang Technological University

Współpracownicy

Ministry of Education, Singapore

Daty zapisu na studia

Daty te śledzą postęp w przesyłaniu rekordów badań i podsumowań wyników do ClinicalTrials.gov. Zapisy badań i zgłoszone wyniki są przeglądane przez National Library of Medicine (NLM), aby upewnić się, że spełniają określone standardy kontroli jakości, zanim zostaną opublikowane na publicznej stronie internetowej.

Główne daty studiów

Rozpoczęcie studiów (Rzeczywisty)

18 sierpnia 2020

Zakończenie podstawowe (Rzeczywisty)

11 lutego 2021

Ukończenie studiów (Rzeczywisty)

11 lutego 2021

Daty rejestracji na studia

Pierwszy przesłany

26 kwietnia 2026

Pierwszy przesłany, który spełnia kryteria kontroli jakości

6 maja 2026

Pierwszy wysłany (Rzeczywisty)

13 maja 2026

Aktualizacje rekordów badań

Ostatnia wysłana aktualizacja (Rzeczywisty)

18 sierpnia 2026

Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości

17 sierpnia 2026

Ostatnia weryfikacja

1 kwietnia 2026

Więcej informacji

Terminy związane z tym badaniem

Słowa kluczowe

Dodatkowe istotne warunki MeSH

Inne numery identyfikacyjne badania

  • IRB 2019-07-039

Plan dla danych uczestnika indywidualnego (IPD)

Planujesz udostępniać dane poszczególnych uczestników (IPD)?

TAK

Opis planu IPD

IPD sharing will be available upon request.

Kryteria dostępu do udostępniania IPD

Individual participant data (IPD) will be made available to qualified researchers upon request. To access the data, researchers must submit a formal request, which will be reviewed and approved by the data sharing committee. Data access will be granted for research purposes only and will require adherence to data use agreements and ethics guidelines.

Typ informacji pomocniczych dotyczących udostępniania IPD

  • PROTOKÓŁ BADANIA
  • SOK ROŚLINNY
  • ICF

Informacje o lekach i urządzeniach, dokumenty badawcze

Bada produkt leczniczy regulowany przez amerykańską FDA

Nie

Bada produkt urządzenia regulowany przez amerykańską FDA

Nie

Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .

Subskrybuj